EU Panel Backs Two Triple Combo Drugs for COPD Maintenance EU Panel Backs Two Triple Combo Drugs for COPD Maintenance

CHF 5993 and Trydonis, from Chiesi Farmaceutici SpA, combine a glucocorticoid, a long-acting beta-2 receptor agonist, and a long-acting muscarinic antagonist.International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news